Literature DB >> 9389500

Regulation of pituitary V1b vasopressin receptor messenger ribonucleic acid by adrenalectomy and glucocorticoid administration.

C Rabadan-Diehl1, G Makara, A Kiss, S Lolait, D Zelena, T Ochedalski, G Aguilera.   

Abstract

Regulation of the number of pituitary vasopressin (VP) receptors plays an important role in controlling pituitary responsiveness during alterations of the hypothalamic pituitary adrenal axis. The mechanisms regulating these VP receptors were studied by analysis of the effects of adrenalectomy and glucocorticoid administration on V1b receptor (V1b-R) messenger RNA (mRNA) by Northern blot and by in situ hybridization in the rat. Adrenalectomy transiently decreased V1b-R mRNA levels by 18 h (77% and 62% for the 3.7-kb and 3.2-kb bands in the Northern blots, and 50% by in situ hybridization), returning to basal levels after 6 days. The decrease in V1b-R mRNA after 18 h adrenalectomy was fully prevented by dexamethasone (100 microg s.c.) but not by elimination of hypothalamic CRH and VP by paraventricular nucleus lesions or median eminence deafferentation. In sham-operated rats, dexamethasone increased receptor mRNA by 50% after 6 days. In contrast to Sprague-Dawley rats, in Brattleboro rats (di/di), which lack hypothalamic VP, adrenalectomy caused a sustained decrease in V1b-R mRNA levels (<50% of controls by 6 days). The data show that pituitary V1b-R mRNA is positively regulated by glucocorticoids and that the recovery of V1b-R mRNA levels after prolonged adrenalectomy is probably mediated by VP. In addition, the data suggest that the down-regulation of VP binding after long-term adrenalectomy is due to posttranscriptional events rather than to changes in V1b-R mRNA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9389500     DOI: 10.1210/endo.138.12.5580

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Differential roles of amygdaloid nuclei in the anxiolytic- and antidepressant-like effects of the V1b receptor antagonist, SSR149415, in rats.

Authors:  N Salomé; J Stemmelin; C Cohen; G Griebel
Journal:  Psychopharmacology (Berl)       Date:  2006-06-02       Impact factor: 4.530

Review 2.  Hypothalamic-pituitary-adrenal axis function during perinatal depression.

Authors:  Phillipe Leff Gelman; Mónica Flores-Ramos; Margarita López-Martínez; Carlos Cruz Fuentes; Juan Pablo Reyes Grajeda
Journal:  Neurosci Bull       Date:  2015-03-02       Impact factor: 5.203

3.  The vasopressin 1b receptor is prominent in the hippocampal area CA2 where it is unaffected by restraint stress or adrenalectomy.

Authors:  W S Young; J Li; S R Wersinger; M Palkovits
Journal:  Neuroscience       Date:  2006-10-04       Impact factor: 3.590

4.  Bacterial lipopolysaccharide-induced coordinate downregulation of arginine vasopressin receptor V3 and corticotropin-releasing factor receptor 1 messenger ribonucleic acids in the anterior pituitary of endotoxemic steers.

Authors:  Isam M Qahwash; Carolyn A Cassar; Roy P Radcliff; George W Smith
Journal:  Endocrine       Date:  2002-06       Impact factor: 3.633

Review 5.  The Mechanisms Underlying Autonomous Adrenocorticotropic Hormone Secretion in Cushing's Disease.

Authors:  Hidenori Fukuoka; Hiroki Shichi; Masaaki Yamamoto; Yutaka Takahashi
Journal:  Int J Mol Sci       Date:  2020-11-30       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.